These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25909288)

  • 1. OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.
    Kim JH; Lee SM; Lee JH; Chun S; Kang BH; Kwak S; Roe JS; Kim TW; Kim H; Kim WH; Cho EJ; Youn HD
    Oncotarget; 2015 Aug; 6(23):19528-41. PubMed ID: 25909288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.
    Singleton RS; Liu-Yi P; Formenti F; Ge W; Sekirnik R; Fischer R; Adam J; Pollard PJ; Wolf A; Thalhammer A; Loenarz C; Flashman E; Yamamoto A; Coleman ML; Kessler BM; Wappner P; Schofield CJ; Ratcliffe PJ; Cockman ME
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4031-6. PubMed ID: 24550447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
    Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OGFOD1, a member of the 2-oxoglutarate and iron dependent dioxygenase family, functions in ischemic signaling.
    Saito K; Adachi N; Koyama H; Matsushita M
    FEBS Lett; 2010 Aug; 584(15):3340-7. PubMed ID: 20579638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
    Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
    Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
    Wang Y; Jin T; Dai X; Xu J
    Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators.
    Fujisaki T; Saito K; Kikuchi T; Kondo E
    FEBS Lett; 2023 Apr; 597(8):1073-1085. PubMed ID: 36464654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.
    Kong X; Duan Y; Sang Y; Li Y; Zhang H; Liang Y; Liu Y; Zhang N; Yang Q
    J Cell Physiol; 2019 Jun; 234(6):9105-9117. PubMed ID: 30362551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells.
    Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R
    Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OGFOD1 negatively regulated by miR-1224-5p promotes proliferation in human papillomavirus-infected laryngeal papillomas.
    Yin D; Wang Q; Wang S; Zhu G; Tang Q; Liu J
    Mol Genet Genomics; 2020 May; 295(3):675-684. PubMed ID: 32002629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
    PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
    Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
    Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
    Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing.
    Stoehr A; Kennedy L; Yang Y; Patel S; Lin Y; Linask KL; Fergusson M; Zhu J; Gucek M; Zou J; Murphy E
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31112528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
    Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
    Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling.
    Wang C; Wang C; Wei Z; Li Y; Wang W; Li X; Zhao J; Zhou X; Qu X; Xiang F
    Cancer Lett; 2015 Nov; 368(1):105-114. PubMed ID: 26272184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.